Mark-India Biologicals Profile
Key Indicators
- Authorised Capital ₹ 0.10 M
as on 30-06-2024
- Paid Up Capital ₹ 0.10 M
as on 30-06-2024
- Company Age 6 Year, 4 Months
- Last Filing with ROC 31 Mar 2019
About Mark-India Biologicals
The Company is engaged in the Chemicals And Resources Industry.
The Company's status is Active, and it has filed its Annual Returns and Financial Statements up until 31 March 2019. It's a company limited by shares with an authorized capital of Rs 0.10 M and a paid-up capital of Rs 0.10 M, as per Ministry of Corporate Affairs (MCA) records.
Imran Shaikh, Faheem Khan, Niraj Singh, and One other member serve as directors at the Company.
- CIN/LLPIN
U24290MP2018PTC045907
- Company No.
045907
- Company Classification
Private Limited Indian Non-Government Company
- Incorporation Date
28 May 2018
- Date of AGM
27 Sep 2019
- Date of Balance Sheet
31 Mar 2019
- Listing Status
Unlisted
- ROC Code
Roc Gwalior
Industry
Company Details
- Location
Indore, Madhya Pradesh, India
- Telephone
- Email Address
- Website
-
- Social Media-
Who are the key members and board of directors at Mark-India Biologicals?
Board Members(4)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
Anilkumar Maurya  | Director | 28-May-2018 | Current |
| Imran Shaikh | Director | 07-Jul-2020 | Current |
| Faheem Khan | Director | 07-Jul-2020 | Current |
| Niraj Singh | Director | 15-Feb-2023 | Current |
Financial Performance and Corporate Structure Insights of Mark-India Biologicals.
Mark-India Biologicals Private Limited, for the financial year ended 2019, experienced no change in revenue, with a 0% increase. The company also saw a no change in profitability, with a 0% increase in profit. The company's net worth witnessed no change by increase of 0%.
- Key Matrics
- Balance Sheet
- Profit and Loss
- Cash Flow
- Ratios
| Metric |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue | |||||||
| Revenue from Operations | |||||||
| Total Assets | |||||||
| Profit or Loss | |||||||
| Net Worth | |||||||
| EBITDA |
What is the Ownership and Shareholding Structure of Mark-India Biologicals?
In 2019, Mark-India Biologicals had a promoter holding of 100.00%. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.
Related Corporates (Common Directorship)
Nmci Inspections And Survey Company Private Limited
Active
18 years 7 months Anilkumar Maurya is a mutual person
Whitefox Media & Entertainment Private Limited
Active 9 years 7 months Imran Shaikh is a mutual person
Saanvi Academy Of Skills And Creative Arts Private Limited
Active 8 years 3 months Imran Shaikh is a mutual person
Charges (Loans)
There are no open charges registered against the company as per our records.
How Many Employees Work at Mark-India Biologicals?
Unlock and access historical data on people associated with Mark-India Biologicals, such as employment history, contributions to the Employees' Provident Fund Organization (EPFO), and related information.
Deals i
Gain comprehensive insights into the Deals and Valuation data of Mark-India Biologicals, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Mark-India Biologicals's trajectory.
Rating
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Alerts
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
